PharmGen Science, Inc. (004720.KS)
KRW 4370.0
(-1.47%)
KRW 4370.0
(-1.47%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 166.77 Billion | 150.93 Billion | 109.86 Billion | 96.61 Billion | 95.13 Billion | 89.1 Billion |
| Cost of Revenue | 70.57 Billion | 69.62 Billion | 49.06 Billion | 43.01 Billion | 44.73 Billion | 42.89 Billion |
| Gross Profit | 96.19 Billion | 81.3 Billion | 60.8 Billion | 53.59 Billion | 50.39 Billion | 46.2 Billion |
| Operating Expenses | 87.07 Billion | 73.81 Billion | 65.74 Billion | 54.04 Billion | 49.2 Billion | 41.21 Billion |
| Selling, General and Administrative Expenses | 61.86 Billion | 47.82 Billion | 38.97 Billion | 31.15 Billion | 27.57 Billion | 20.66 Billion |
| Research and Development Expenses | 5.11 Billion | 2.88 Billion | 2.26 Billion | 1.11 Billion | 886.29 Million | 1.23 Billion |
| Other Expenses | 21.76 Billion | 23.11 Billion | 24.49 Billion | 21.77 Billion | 20.73 Billion | -227.02 Million |
| Cost and Expenses | 157.65 Billion | 143.44 Billion | 114.8 Billion | 97.06 Billion | 93.94 Billion | 84.11 Billion |
| Operating Income | 9.12 Billion | 95.02 Billion | 42.49 Billion | 14.22 Billion | 1.18 Billion | 4.98 Billion |
| Interest Expense | 4.26 Billion | 3.5 Billion | 1.72 Billion | 289.55 Million | 1.47 Billion | 246.2 Million |
| Income Tax Expense | 2.26 Billion | 19.9 Billion | 9.53 Billion | 2.08 Billion | 168.18 Million | -603.11 Million |
| Earnings before Tax | 7.99 Billion | 89.96 Billion | 41.94 Billion | 11.2 Billion | 404.17 Million | 3.89 Billion |
| Net Income | 5.72 Billion | 70.05 Billion | 32.46 Billion | 9.22 Billion | 235.99 Million | 4.46 Billion |
| Earnings Per Share Basic | 351.99 | 4498.10 | 2206.02 | 674.98 | 20.45 | 390.15 |
| Earnings Per Share Diluted | 275.40 | 3369.29 | 1814.33 | 623.34 | 20.45 | 390.00 |
| Weighted Average Shares Outstanding | 16.27 Million | 15.57 Million | 14.71 Million | 13.66 Million | 11.54 Million | 11.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 20.79 Million | 21.59 Million | 18.59 Million | 15.02 Million | 11.54 Million | 11.45 Million |
| Gross Margin | 0.58 | 0.54 | 0.55 | 0.55 | 0.53 | 0.52 |
| EBIT Margin | 0.08 | 0.65 | 0.42 | 0.18 | 0.04 | 0.07 |
| Profit Margin | 0.03 | 0.46 | 0.30 | 0.10 | 0.00 | 0.05 |
| EBITDA | 13.37 Billion | 10.78 Billion | -1.79 Billion | 1.05 Billion | 3.51 Billion | 6.17 Billion |
| Earnings Before Tax Margin | 0.05 | 0.63 | 0.39 | 0.15 | 0.01 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 42.9 Billion | 42.5 Billion | 166.77 Billion | 46.53 Billion | 41.14 Billion | 41.49 Billion |
| Cost of Revenue | 16.56 Billion | 16.79 Billion | 70.57 Billion | 19.67 Billion | 17.26 Billion | 16.61 Billion |
| Gross Profit | 26.33 Billion | 25.71 Billion | 96.19 Billion | 26.86 Billion | 23.88 Billion | 24.87 Billion |
| Operating Expenses | 23.61 Billion | 22.7 Billion | 87.07 Billion | 22.85 Billion | -23.14 Billion | 22.45 Billion |
| Selling, General and Administrative Expenses | 22.52 Billion | 21.59 Billion | - | 22.8 Billion | 23.14 Billion | 22.45 Billion |
| Research and Development Expenses | 1.02 Billion | 1.08 Billion | - | 1.37 Billion | 1.46 Billion | 1.67 Billion |
| Other Expenses | -73.12 Million | -28.33 Million | -206.93 Million | -43.79 Million | -46.29 Billion | -35.36 Million |
| Cost and Expenses | 40.18 Billion | 39.49 Billion | 157.65 Billion | 42.52 Billion | 17.26 Billion | 16.61 Billion |
| Operating Income | 2.71 Billion | 3.01 Billion | 9.12 Billion | 4.01 Billion | 742.19 Million | 2.42 Billion |
| Interest Expense | 2.52 Billion | 992.44 Million | 4.26 Billion | 1.19 Billion | 1.2 Billion | 1.16 Billion |
| Income Tax Expense | 926.67 Million | 642.6 Million | 2.26 Billion | -443.04 Million | 86.17 Million | 2 Billion |
| Earnings before Tax | 1.8 Billion | 2.01 Billion | 10.25 Billion | 2.88 Billion | -2.03 Billion | 8.7 Billion |
| Net Income | 1.05 Billion | 1.94 Billion | 5.72 Billion | -321.13 Million | -2.12 Billion | 6.7 Billion |
| Earnings Per Share Basic | 57.91 | 107.41 | - | -17.88 | -132.96 | 424.18 |
| Earnings Per Share Diluted | 54.00 | 97.00 | - | -17.88 | -132.96 | 335.00 |
| Weighted Average Shares Outstanding | 18.13 Million | 18.13 Million | 16.27 Million | 17.96 Million | 15.95 Million | 15.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.44 Million | 20.08 Million | 20.79 Million | 17.96 Million | 15.95 Million | 18 Million |
| Gross Margin | 0.61 | 0.60 | 0.58 | 0.58 | 0.58 | 0.60 |
| EBIT Margin | 0.09 | 0.10 | - | 0.11 | 0.58 | 0.60 |
| Profit Margin | 0.02 | 0.05 | 0.03 | -0.01 | -0.05 | 0.16 |
| EBITDA | 3.88 Billion | 4.16 Billion | - | 5.17 Billion | 23.88 Billion | 24.87 Billion |
| Earnings Before Tax Margin | 0.06 | 0.07 | 0.05 | 0.09 | 0.02 | 0.06 |
CNUTF
8362
LCE
118000
DS
GGBXF